Literature DB >> 31559160

Role of imaging in the diagnosis of vascular malformations vascular malformations.

Katayoun Samadi1, Gloria Maria Salazar1.   

Abstract

Imaging evaluation of vascular malformations (VM) is paramount for proper diagnosis and treatment planning. These lesions often present as complex vascular masses with arterial, venous and lymphatic components, requiring the use of advanced imaging modalities for full anatomical characterization. Symptoms also depend of the location and flow characteristic of such lesions and range from: asymptomatic to severe forms of cardiac arteriovenous shunting. We present an overview of the diagnostic work-up of VM per most recent classification systems and describe imaging characteristics of such lesions at ultrasonography (US) and magnetic resonance imaging (MRI) as a diagnostic tool for work-up of such patients.

Entities:  

Keywords:  Magnetic resonance imaging (MRI); ultrasound; vascular malformation (VM)

Year:  2019        PMID: 31559160      PMCID: PMC6732108          DOI: 10.21037/cdt.2018.08.06

Source DB:  PubMed          Journal:  Cardiovasc Diagn Ther        ISSN: 2223-3652


  3 in total

Review 1.  Neonatal vascular anomalies manifesting as soft-tissue masses.

Authors:  Nadeen Abu Ata; Adrienne M Hammill; Arnold C Merrow
Journal:  Pediatr Radiol       Date:  2021-08-10

2.  A case of a large leiomyomatous uterus with multiple arteriovenous malformations and subsequent high cardiac output state with severe four chamber cardiac enlargement.

Authors:  Beatriz Vega; Andrew H Stockland; Rachel M Bramblet; Alexandra L Anderson; Rekha Mankad; Zaraq Khan; Mohamed Mustafa; Joan M Steyermark; Amanda R Fields; Novette J Berntson; J Kenneth Schoolmeester; Jill J Colglazier; Jamie N Bakkum-Gamez
Journal:  Gynecol Oncol Rep       Date:  2021-11-26

3.  Papillary Endothelial Hyperplasia (Masson Tumor) of the Hand. Surgical and Pathological Consideration from Seven Cases Using New Vascular Markers.

Authors:  Bernadett Bettina Patai; Nora Peterfy; Noemi Szakacs; Zoltan Sapi; Judit Reka Hetthessy
Journal:  Pathol Oncol Res       Date:  2020-07-15       Impact factor: 3.201

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.